Generic versions of Victoza and Saxenda are now available in some countries, but no generic liraglutide products are yet registered and available in South Africa
Betul Ibis and colleagues, used the TriNetX database to compare 217,302 diabetes patients on GLP-1 medications with 217,302 matched patients on DPP-4 inhibitors. Patients on GLP-1s had a significantly lower risk of developing rheumatoid arthritis (HR = 0.87, p = 0.026), gout, and osteoarthritis within one year
Alzheimers Res Ther (2021) 13(1):80
Month-by-Month Results Timeline The following timeline reflects the general pattern our providers observe as patients move through dose escalation
1,961 participants with BMI of 30+ (or 27+ with at least one weight-related condition) received either semaglutide 2.4 mg or placebo weekly for 68 weeks, alongside lifestyle intervention